Stay updated on Nivolumab+RT+Bevacizumab in Recurrent Methylated Glioblastoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab+RT+Bevacizumab in Recurrent Methylated Glioblastoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab+RT+Bevacizumab in Recurrent Methylated Glioblastoma Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    The page’s footer/version indicator has been updated from Revision v3.5.2 to v3.5.3, reflecting a site release rather than a modification to the clinical trial information.
    Difference
    0.0%
    Check dated 2026-04-25T18:47:09.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-18T13:43:53.000Z thumbnail image
  5. Check
    57 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-21T01:20:42.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-06T18:22:44.000Z thumbnail image
  7. Check
    93 days ago
    Change Detected
    Summary
    The change updates the page revision from v3.4.1 to v3.4.2, with no observed changes to study details or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-13T11:58:01.000Z thumbnail image
  8. Check
    100 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.0 to v3.4.1. This update does not affect study information or user-facing content.
    Difference
    0.0%
    Check dated 2026-02-05T15:08:01.000Z thumbnail image

Stay in the know with updates to Nivolumab+RT+Bevacizumab in Recurrent Methylated Glioblastoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab+RT+Bevacizumab in Recurrent Methylated Glioblastoma Clinical Trial page.